Ono and Shattuck collaborate on bifunctional fusion proteins for autoimmune and inflammatory diseases
Feb. 13, 2024
Ono Pharmaceutical Co. Ltd. has entered into a drug discovery collaboration and option agreement with Shattuck Labs Inc. to generate bifunctional fusion proteins.